The neurofibromatoses are complex multi-system disorders that require lifelong surveillance and expert management and holistic care from a team of dedicated multi-disciplinary experts. There is an increased risk of benign and malignant tumor formation and many complications cause significant clinical and psychological morbidity.  

Currently there are different approaches to medical management of these conditions and prospective natural history studies are required. The advent of novel therapy requires standardized neurological, imaging and quality of life outcome measures. 

Patients have expressed having difficulties with access to care of physicians familiar with the treatment of this complicated rare disease. The conference attracts more medical professionals to serve this unmet need. It also allows the newest research and clinical practices to be disseminated.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Medical College of Wisconsin and Children’s Tumor Foundation. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
 
The Medical College of Wisconsin designates this live activity for a maximum of 20.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Medical College of Wisconsin designates this activity for up to 20.25 hours of participation for continuing education for allied health professionals.